WallStreetZenWallStreetZen
Analyst Ranking
Top 14%
#638 out of 4565 analysts
Average Return
+9.49%
Win Rate
53%34 out of 64
Risk vs Reward
Poor
Good

Adam Maeder's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inspire Medical Systems IncINSP
+238.11%$64.61$218.45
2020-04-08 -
2021-04-09
Strong Buy
Tactile Systems Technology IncTCMD
+149.02%$9.16$22.81
2022-08-01 -
2023-08-01
Strong Buy
Nyxoah SaNYXH
+130.88%$4.89$11.29
2023-11-08 -
2024-04-25
Strong Buy
Inspire Medical Systems IncINSP
+96.50%$126.85$249.26
2020-09-17 -
2021-09-17
Strong Buy
Apollo Endosurgery IncAPEN
+68.40%$4.81$8.10
2020-11-29 -
2021-11-29
Strong Buy

Adam Maeder Analyst Color

Get additional color on Adam Maeder's coverage of popular stocks

Adam Maeder's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Intuitive Surgical IncISRG
12Strong Buy$435.00+16.58%Maintains
7 days ago
Shockwave Medical IncSWAV
8Strong Buy$360.00+9.43%Maintains
24 days ago
Neuronetics IncSTIM
1Strong Buy$8.00+127.27%Reiterates
2 months ago
Nyxoah SaNYXH
8Strong Buy$20.00+77.15%Maintains
2 months ago
Vicarious Surgical IncRBOT
4Hold$1.00+280.23%Maintains
2 months ago
Silk Road Medical IncSILK
5Hold$18.00+1.98%Maintains
2 months ago
Macy's IncM
1Hold$20.00+8.99%Downgrades
2 months ago
Inari Medical IncNARI
3Hold$55.00+44.47%Downgrades
2 months ago
Axonics IncAXNX
6Hold$71.00+6.70%Downgrades
3 months ago
Nevro CorpNVRO
11Strong Sell$15.00+29.09%Maintains
6 months ago
Inspiremd IncNSPR
2Strong Buy$4.50+134.99%Maintains
6 months ago
Edwards Lifesciences CorpEW
9Hold$68.00-22.74%Maintains
6 months ago
Tactile Systems Technology IncTCMD
2Strong Buy$30.00+110.23%Maintains
a year ago
Stereotaxis IncSTXS
2Strong Buy$5.00N/AMaintains
a year ago
Inspire Medical Systems IncINSP
10Strong Buy$305.00N/AMaintains
a year ago
Zynex IncZYXI
2Strong Buy$18.00N/AUpgrades
a year ago
Livanova PLCLIVN
3Strong Buy$99.00N/AMaintains
2 years ago
Apollo Endosurgery IncAPEN
4Strong Buy$11.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.